HEREDITARY ANGIOEDEMA - TYPE 1
Clinical trials for HEREDITARY ANGIOEDEMA - TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA - TYPE 1 trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA - TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New RNA drug aims to stop debilitating swelling attacks in rare genetic condition
Disease control Recruiting nowThis phase 3 trial is testing an experimental drug called ADX-324 in 90 adults with hereditary angioedema (HAE) types 1 or 2. HAE causes sudden, painful swelling in the body. ADX-324 uses a technology called siRNA to lower levels of a protein involved in triggering these attacks.…
Matched conditions: HEREDITARY ANGIOEDEMA - TYPE 1
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New RNA drug shows promise in preventing HAE attacks in ongoing study
Disease control Recruiting nowThis study is for people with hereditary angioedema (HAE) who have already completed a previous trial of the drug ADX-324. ADX-324 is an RNA-based medicine designed to lower a protein involved in swelling attacks. The goal is to see if long-term use is safe and can reduce the num…
Matched conditions: HEREDITARY ANGIOEDEMA - TYPE 1
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Smartphone study reveals hidden toll of hereditary angioedema
Knowledge-focused Recruiting nowThis study uses smartphone surveys to track the real-life burden of hereditary angioedema (HAE) in 30 adults. Participants answer quick questions about their symptoms, mood, and daily activities every other day for 8 weeks. The goal is to capture day-to-day changes that standard …
Matched conditions: HEREDITARY ANGIOEDEMA - TYPE 1
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC